Fred Hutch announces 10 recipients of the annual Harold M. Weintraub Graduate Student Award

Since 1991, the Women’s Health Initiative has saved lives, cut costs, and fostered team science

When the Women’s Health Initiative was announced in 1991, it was set to be the largest women’s health study ever conducted. The WHI scope is massive: the initiative has recruited more than 161,000 women and engaged more than 5,000 scientists from the U.S. and beyond.

July 03, 2025

Vol.51 No.26

Clinical Roundup

Scientists uncover new approach for targeting aggressive breast cancer

A recent study from cancer researchers at the University of Alabama at Birmingham and Georgia State University has identified a new therapeutic target in quadruple-negative breast cancer, or QNBC, one of the deadliest and most aggressive treatment-resistant forms of breast cancer.

July 03, 2025

Vol.51 No.26

In Brief

Ric Anderson, Eduardo Peñalver named to Fred Hutch board of directors, Jim Lico becomes member

Ric AndersonEduardo PeñalverJim LicoRic Anderson was elected chair of the Fred Hutchinson Cancer Center’s board of directors, and Eduardo Peñalver was named vice chair, effective July 1.

June 27, 2025

Vol.51 No.25

In Brief

Fred Hutch announces eight recipients of 2025 Dr. Eddie Méndez Scholar Award

2025 Dr. Eddie Méndez Scholar Award Recipients, top row left to right: Caitlin Cornell, PhD, Elizabeth Kaweesa, PhD, Leandro Fernández-García, PhD, Almudena Chaves Pérez, PhD. Bottom row left to right: Luis Cedeño-Rosario, PhD, Nicole Halmai, PhD, Megan E. Meuser, PhD, Sarah Elisabeth Pierce, PhD. Fred Hutch Cancer Center has announced eight recipients of the 2025 Dr. Eddie Méndez Scholar Award.

June 20, 2025

Vol.51 No.24

In Brief

UNC Lineberger awarded up to $28M from ARPA-H to develop clinical trial for metastatic breast cancer

UNC Lineberger Comprehensive Cancer Center has been awarded up to $28 million by the Advanced Research Projects Agency for Health to lead the development of a next-generation clinical trial for breast cancer that has spread to other parts of the body.

June 20, 2025

Vol.51 No.24

Drugs & Targets

Clairity becomes the first FDA-authorized AI platform for breast cancer prediction

Clairity Inc. received FDA De Novo authorization for CLAIRITY BREAST, a novel, image-based prognostic platform designed to predict five-year breast cancer risk from a routine screening mammogram. With this authorization, Clairity is planning to launch among leading health systems through 2025—propelling a new era of precision medicine in breast cancer.

June 06, 2025

Vol.51 No.22

Fred Hutch announces 10 recipients of the annual Harold M. Weintraub Graduate Student Award

YOU MAY BE INTERESTED IN

Since 1991, the Women’s Health Initiative has saved lives, cut costs, and fostered team science

Scientists uncover new approach for targeting aggressive breast cancer

Ric Anderson, Eduardo Peñalver named to Fred Hutch board of directors, Jim Lico becomes member

Fred Hutch announces eight recipients of 2025 Dr. Eddie Méndez Scholar Award

UNC Lineberger awarded up to $28M from ARPA-H to develop clinical trial for metastatic breast cancer

Clairity becomes the first FDA-authorized AI platform for breast cancer prediction

Renew today!

Subscriber content

Never miss an issue!

Login